Literature DB >> 7872587

Health values of the seriously ill. SUPPORT investigators.

J Tsevat1, E F Cook, M L Green, D B Matchar, N V Dawson, S K Broste, A W Wu, R S Phillips, R K Oye, L Goldman.   

Abstract

OBJECTIVE: To assess 1) the health values and health ratings of seriously ill hospitalized patients, their surrogate decision makers, and their physicians; 2) the determinants of health values; and 3) whether health values change over time.
DESIGN: Prospective, longitudinal, multicenter study.
SETTING: 5 academic medical centers. PARTICIPANTS: 1438 seriously ill patients with at least one of nine diseases who had a projected overall 6-month mortality rate of 50%; their surrogates; and their physicians. MEASUREMENTS: Time-tradeoff utilities (reflecting preferences for a shorter but healthy life) and health ratings.
RESULTS: At study day 3, patients had a mean time-tradeoff utility of 0.73 +/- 0.32 (median [25th, 75th percentile], 0.92 [0.63, 1.0]), indicating that they equated living 1 year in their current state of health with living 8.8 months in excellent health. However, scores varied widely; 34.8% of patients were unwilling to exchange any time in their current state of health for a shorter life in excellent health (utility, 1.0), and 9.0% were willing to live 2 weeks or less in excellent health rather than 1 year in their current state of health (utility, 0.04). Health rating scores averaged 57.8 +/- 24.0 (median [25th percentile, 75th percentile], 60 [50, 75]) on a scale of 0 (death) to 100 (perfect health). The patients' mean time-tradeoff score exceeded that of their paired surrogates (n = 1041) by 0.08 (P < 0.0001). Time-tradeoff scores were related to psychosocial well-being; health ratings; desire for resuscitation and extension of life rather than relief of pain and discomfort; degree of willingness to live with constant pain; and perceived prognosis for survival and independent functioning. Scores of surviving patients increased by an average of 0.06 after 2 months (P < 0.0001) and 0.08 after 6 months (P < 0.0001).
CONCLUSIONS: Health values of seriously ill patients vary widely, are higher than patients' surrogates believe, are related to few other preference and health status measures, and increase over time.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health; Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT)

Mesh:

Year:  1995        PMID: 7872587     DOI: 10.7326/0003-4819-122-7-199504010-00007

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  24 in total

1.  Surviving intensive care: a report from the 2002 Brussels Roundtable.

Authors:  Derek C Angus; Jean Carlet
Journal:  Intensive Care Med       Date:  2003-01-21       Impact factor: 17.440

Review 2.  Qualitative research in medicine and health care: questions and controversy.

Authors:  R M Poses; A M Isen
Journal:  J Gen Intern Med       Date:  1998-01       Impact factor: 5.128

3.  Communication with the seriously ill: physicians' attitudes in Saudi Arabia.

Authors:  A F Mobeireek; F A al-Kassimi; S A al-Majid; A al-Shimemry
Journal:  J Med Ethics       Date:  1996-10       Impact factor: 2.903

4.  Cost-utility analysis of melphalan plus prednisone with or without interferon-alpha 2b in newly diagnosed multiple myeloma. Results from a randomised controlled trial.

Authors:  E Nord; F Wisløff; M Hjorth; J Westin
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

5.  Quadrimodal distribution of death after trauma suggests that critical injury is a potentially terminal disease.

Authors:  Heena P Santry; Charles M Psoinos; Christopher J Wilbert; Julie M Flahive; Aimee R Kroll-Desrosiers; Timothy A Emhoff; Catarina I Kiefe
Journal:  J Crit Care       Date:  2015-01-08       Impact factor: 3.425

6.  Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public.

Authors:  Peter A Ubel; George Loewenstein; Christopher Jepson
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

7.  Expectations and outcomes of prolonged mechanical ventilation.

Authors:  Christopher E Cox; Tereza Martinu; Shailaja J Sathy; Alison S Clay; Jessica Chia; Alice L Gray; Maren K Olsen; Joseph A Govert; Shannon S Carson; James A Tulsky
Journal:  Crit Care Med       Date:  2009-11       Impact factor: 7.598

8.  Cost-effectiveness of ceftazidime-avibactam for treatment of carbapenem-resistant Enterobacteriaceae bacteremia and pneumonia.

Authors:  Matthew S Simon; Maroun M Sfeir; David P Calfee; Michael J Satlin
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

Review 9.  Strategies for improving quality of life in older patients with metastatic breast cancer.

Authors:  Jean-Emmanuel Kurtz; Patrick Dufour
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

10.  Health state valuation in mild to moderate cognitive impairment: feasibility of computer-based, direct patient utility assessment.

Authors:  Neal V Dawson; Mendel E Singer; Leslie Lenert; Marian B Patterson; Susie A Sami; Iahn Gonsenhouser; Heather A Lindstrom; Kathleen A Smyth; Melissa J Barber; Peter J Whitehouse
Journal:  Med Decis Making       Date:  2008-03-18       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.